Thurston Springer Miller Herd & Titak’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
12,877
+2,205
| +21% | +$409K | 0.31% | 88 |
|
|
2025
Q1 | $2.24M | Buy |
10,672
+462
| +5% | +$96.8K | 0.38% | 72 |
|
|
2024
Q4 | $1.81M | Buy |
10,210
+1,392
| +16% | +$247K | 0.37% | 68 |
|
|
2024
Q3 | $1.74M | Sell |
8,818
-257
| -3% | -$50.8K | 0.48% | 50 |
|
|
2024
Q2 | $1.56M | Sell |
9,075
-38,810
| -81% | -$6.66M | 0.48% | 46 |
|
|
2024
Q1 | $8.72M | Buy |
+47,885
| New | +$8.72M | 3.5% | 7 |
|